The Maastricht Consensus Conference on Thrombosis (MCCT) will be a hybrid meeting containing both active as well as more "passive" elements (intensive workshops, and plenary lectures). Consensus will be sought on future directions for research.
The Maastricht Consensus Conference on Thrombosis will be theme-focused and will involve clinicians, epidemiologists and basic scientists, who will jointly explore new avenues for research in the area of thrombosis and haemostasis. The Maastricht Consensus Conference on Thrombosis is a 3 day meeting, involving plenary lectures by prominent scientists and experts in the field on a chosen theme, followed by highly interactive, intensive workshops in which the interaction between the experienced scientists, PhD students and postdocs is used to explore gaps in research or knowledge on specific topics.

This 2017 Maastricht Consensus Conference on Thrombosis (MCCT) has as a main theme: ’Atherothrombosis and thromboembolism’

This is a highly interactive working conference where scientists from all backgrounds, including academia and industry, interact with the audience on “hot topics” in cardiovascular diseases with a focus on atherothrombosis, including atrial fibrillation, ischemic stroke, acute coronary syndrome and peripheral artery disease.

Conference topics include:
• Pleiotropy of coagulation proteases and platelets in the pathogenesis of atherothrombosis and embolic stroke
• Biomarkers and risk stratification 
• Optimized individual antithrombotic management (novel anticoagulants and antiplatelet agents)
• Invasive thrombus resolution and reperfusion injury in legs, heart and brain
• Plenary session: Unsolved clinical issues (eg monitoring NOAC’s?)